Aptevo Therapeutics (APVO) Return on Sales [ROS] (2015 - 2022)
Aptevo Therapeutics (APVO) recorded Return on Sales [ROS] of -919.75% in Q4 2022, down 809.52 percentage points from -110.23% a year earlier and down 551.01 percentage points from the prior quarter.
Powered by 
Analysis
Aptevo Therapeutics (APVO) Return on Sales [ROS] (2015 - 2022) Analysis & Trends
Starting with Q2 2015, Aptevo Therapeutics' Return on Sales [ROS] history includes 30 quarters.
- Annual Return on Sales [ROS] has a five-year change of -551.70 percentage points (FY2017 to FY2022).
- Across earlier years, Return on Sales [ROS] came in at -174.10% in FY2021 (+463.96 pp), -638.06% in FY2020 (-511.73 pp), -126.33% in FY2019 (+97.65 pp) and -223.98% in FY2018 (+144.07 pp).
- The Q4 2022 figure is the lowest quarterly Return on Sales [ROS] since Q2 2020.
- On a year-over-year basis, Return on Sales [ROS] has declined for three consecutive quarters, with an average year-over-year change of +106.69 percentage points over the last seven quarters.
- Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 1255.12 percentage points in Q2 2021, against a drop of 1263.89 percentage points in Q2 2020 at the low end.
- Per Business Quant, the preceding three quarters came in at -368.74% (Q3 2022), -222.41% (Q2 2022) and -180.19% (Q1 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Aptevo Therapeutics | 2.50 Mn | -64.50 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -919.75% |
| Sep 30, 2022 | -368.74% |
| Jun 30, 2022 | -222.41% |
| Mar 31, 2022 | -180.19% |
| Dec 31, 2021 | -110.23% |
| Sep 30, 2021 | -153.42% |
| Jun 30, 2021 | -183.99% |
| Mar 31, 2021 | -284.51% |
| Dec 31, 2020 | -287.36% |
| Sep 30, 2020 | -426.93% |
| Jun 30, 2020 | -1,439.11% |
| Dec 31, 2019 | -87.88% |
| Sep 30, 2019 | -127.17% |
| Jun 30, 2019 | -175.22% |
| Mar 31, 2019 | -162.92% |
| Dec 31, 2018 | -214.18% |
| Sep 30, 2018 | -208.22% |
| Jun 30, 2018 | -182.30% |
| Mar 31, 2018 | -331.64% |
| Dec 31, 2017 | -596.91% |
API Access
Aptevo Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=APVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "APVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=APVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();